Azin Aghamajidi

Dr. Azin Aghamajidi

Iran University of Medical Sciences, Tehran, Tehrān, Iran
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 July 2022 in Cancers
Verified
Journal Article
Open access
PDF file
AAAzin Aghamajidi
Azin Aghamajidi
SVSaman Maleki Vareki
Saman Maleki Vareki
Gut microbiota can have opposing functions from pro-tumorigenic to anti-tumorigenic effects. Increasing preclinical and clinical evidence suggests that the intestinal microbiota affects cancer patients’ response to immune checkpoint inhibitors (ICIs) immunotherapy, such as anti-programmed cell death protein 1 (PD-1) and its ligand (PD-L1) and anti-cytotoxic T lymphocyte-associated protein 4 (CTLA-4). Microbiota-induced inflammation possibly contributes to tumor growth and cancer development. Microbiota-derived metabolites can also be converted to carcinogenic agents related to genetic mutations and DNA damage in organs such as the colon. However, other attributes of microbiota, such as greater diversity and specific bacterial species and their metabolites, are linked to better clinical outcomes and potentially improved anti-tumor immunity. In addition, the intratumoral microbial composition strongly affects T-cell-mediated cytotoxicity and anti-tumor immune surveillance, adding more complexity to the cancer-microbiome-immune axis. Despite the emerging clinical evidence for the activity of the gut microbiota in immuno-oncology, the fundamental mechanisms of such activity are not well understood. This review provides an overview of underlying mechanisms by which the gut microbiota and its metabolites enhance or suppress anti-tumor immune responses. Understanding such mechanisms allows for better design of microbiome-specific treatment strategies to improve the clinical outcome in cancer patients undergoing systemic therapy.

1 January 2023 in The World Journal of Men's Health
Verified
Journal Article
Open access
PDF file
Ashok AgarwalAshok Agarwal
Ashok Agarwal
Rossella CannarellaRossella Cannarella
Rossella Cannarella
Ramadan SalehRamadan Saleh
Ramadan Saleh
FBFlorence Boitrelle
Florence Boitrelle
MGMurat Gul
Murat Gul
RSRupin Shah
Rupin Shah
Agarwal A, et al. World J Mens Health. 2022 Oct;40:e70. https://doi.org/10.5534/wjmh.220142

1 January 2022 in The World Journal of Men's Health
Verified
Journal Article
Open access
PDF file
SGSajal Gupta
Sajal Gupta
RSRakesh Sharma
Rakesh Sharma
Ashok AgarwalAshok Agarwal
Ashok Agarwal
FBFlorence Boitrelle
Florence Boitrelle
Renata FinelliRenata Finelli
Renata Finelli
RSRupin Shah
Rupin Shah
Gupta S, et al. World J Mens Health. 2022 Jan;40:e6. https://doi.org/10.5534/wjmh.210164

29 April 2023 in Archives of Virology
Verified
Journal Article
Open access
PDF file
TNTahereh Nazary
Tahereh Nazary
AAAzin Aghamajidi
Azin Aghamajidi
MDMaryam Dorfaki
Maryam Dorfaki
FKFatemeh Keshavarz
Fatemeh Keshavarz
ZSZahra Shafaghat
Zahra Shafaghat
RJReza Jafari
Reza Jafari
B lymphocytes play a vital role in the human defense against viral infections by producing specific antibodies. They are also critical for the prevention of infectious diseases by vaccination, and their activation influences the efficacy of the vaccination. Since the beginning of coronavirus disease 2019 (COVID-19), which became the main concern of the world health system, many efforts have been made to treat and prevent the disease. However, for the development of successful therapeutics and vaccines, it is necessary to understand the interplay between severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of COVID-19, and the immune system. The innate immune system provides primary and nonspecific defense against the virus, but within several days after infection, a virus-specific immune response is provided first by antibody-producing B cells, which are converted after the resolution of disease to memory B cells, which provide long-term immunity. Although a failure in B cell activation or B cell dysfunction can cause a severe form of the disease and also lead to vaccination inefficiency, some individuals with B cell immunodeficiency have shown less production of the cytokine IL-6, resulting in a better disease outcome. In this review, we present the latest findings on the interaction between SARS-CoV-2 and B lymphocytes during COVID-19 infection.

25 January 2022 in The World Journal of Men's Health
Verified
Journal Article
Open access
PDF file
Ashok AgarwalAshok Agarwal
Ashok Agarwal
Renata FinelliRenata Finelli
Renata Finelli
DDDamayanthi Durairajanayagam
Damayanthi Durairajanayagam
KLKristian Leisegang
Kristian Leisegang
Ralf HenkelRalf Henkel
Ralf Henkel
FBFlorence Boitrelle
Florence Boitrelle
Agarwal A, et al. World J Mens Health. 2022 Oct;40(4):636-652. https://doi.org/10.5534/wjmh.210202

13 May 2022 in Archives of Endocrinology and Metabolism
Verified
Journal Article
Open access
PDF file
FAFatemeh Sadat Amjadi
Fatemeh Sadat Amjadi
ZZZahra Zandieh
Zahra Zandieh
MMmehdi mehdizadeh
mehdi mehdizadeh
MAMarziyeh Ajdary
Marziyeh Ajdary
AAAzin Aghamajidi
Azin Aghamajidi
RAReza Aflatoonian
Reza Aflatoonian
Objective: Despite the treatment of anovulation, infertility is still one of the main complications in PCOS women during reproductive age, which appears to be mainly due to impaired uterine receptivity. This study investigated the transcriptome profiles of endometrium in PCOS patients and healthy fertile individuals as the control group. Material and methods: Total mRNA was extracted from endometrial tissues of PCOS patients (n = 12) and healthy fertile individuals (n = 10) during the luteal phase. After cDNA synthesis, [...] ABSTRACT Objective: Despite the treatment of anovulation, infertility is still one of the main complications in PCOS women during reproductive age, which appears to be mainly due to impaired uterine receptivity. This study investigated the transcriptome profiles of endometrium in PCOS patients and healthy fertile individuals as the control group. Material and methods: Total mRNA was extracted from endometrial tissues of PCOS patients (n = 12) and healthy fertile individuals (n = 10) during the luteal phase. After cDNA synthesis,